Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (58)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Glenn, C. L.
Right arrow Articles by Morris, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glenn, C. L.
Right arrow Articles by Morris, B. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2000, Vol. 9, No. 13 1943-1949
© 2000 Oxford University Press

Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor

Cheryl L. Glenn+, William Y.S. Wang+, Adam V. Benjafield and Brian J. Morris§

Basic & Clinical Genomics Laboratory, Department of Physiology and Institute for Biomedical Research, Building F13, The University of Sydney, Sydney, New South Wales 2006, Australia

Tumor necrosis factor (TNF) receptor 2 (TNF-R2) has been implicated in insulin resistance and metabolic syndrome disorders, one of which is hypertension (HT). We therefore decided to test markers in and near the TNF-R2 gene (TNFRSF1B) for linkage and association with HT, as well as hypercholesterolemia, and plasma levels of the shed soluble receptor (sTNF-R2). The linkage study, which involved 200 HT Anglo-Celtic Caucasian sibpairs, indicated a sharp, significant linkage peak centered at TNFRSF1B (multipoint maximum LOD score = 2.6 and 3.1 by weighted and unweighted MAPMAKER/SIBS, respectively; two-point LOD scores = 2.9 and 3.9 by weighted and unweighted SPLINK, respectively; P = 10–4 by identical-by-state {chi}2). The case–control study in 134 unrelated HTs who were the offspring of two HT parents and 197 normotensives (NTs) whose parents were both NTs, indicated possible association of TNFRSF1B with HT by haplotype analysis (P = 0.008). Plasma sTNF-R2 was elevated in HTs (P < 0.0001) and showed a correlation with systolic and diastolic blood pressure (BP) (P < 0.0002). A genotypic effect of TNFRSF1B on plasma sTNF-R2, as well as total, low and high density lipoprotein cholesterol, and diastolic BP was observed. These observations are consistent with a scheme leading to raised BP and hypercholesterolemia. In conclusion, TNFRSF1B may be a candidate gene for HT and other metabolic syndrome abnormalities.

+ These authors contributed equally to this work

§ To whom correspondence should be addressed. Tel: +61 2 9351 3688; Fax: +61 2 9351 2227; Email: brianm@physiol.usyd.edu.au


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 HypertensionHome page
G. Shi, C. C. Gu, A. T. Kraja, D. K. Arnett, R. H. Myers, J. S. Pankow, S. C. Hunt, and D. C. Rao
Genetic Effect on Blood Pressure Is Modulated by Age: The Hypertension Genetic Epidemiology Network Study
Hypertension, January 1, 2009; 53(1): 35 - 41.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. Barlassina, C. Dal Fiume, C. Lanzani, P. Manunta, G. Guffanti, A. Ruello, G. Bianchi, L. Del Vecchio, F. Macciardi, and D. Cusi
Common genetic variants and haplotypes in renal CLCNKA gene are associated to salt-sensitive hypertension
Hum. Mol. Genet., July 1, 2007; 16(13): 1630 - 1638.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
D. K. Arnett, A. E. Baird, R. A. Barkley, C. T. Basson, E. Boerwinkle, S. K. Ganesh, D. M. Herrington, Y. Hong, C. Jaquish, D. A. McDermott, et al.
Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group
Circulation, June 5, 2007; 115(22): 2878 - 2901.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
Z. Pausova, D. Gaudet, F. Gossard, M. Bernard, M. L. Kaldunski, M. Jomphe, J. Tremblay, T. J. Hudson, G. Bouchard, T. A. Kotchen, et al.
Genome-Wide Scan for Linkage to Obesity-Associated Hypertension in French Canadians
Hypertension, December 1, 2005; 46(6): 1280 - 1285.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
B. J. Morris
Dissecting Hypertension by Obesity Identifies a Locus at 1p36
Hypertension, December 1, 2005; 46(6): 1256 - 1258.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. T. Todorov, S. Volkl, J. Friedrich, L. A. Kunz-Schughart, T. Hehlgans, L. Vermeulen, G. Haegeman, M. L. Schmitz, and A. Kurtz
Role of CREB1 and NF{kappa}B-p65 in the Down-regulation of Renin Gene Expression by Tumor Necrosis Factor {alpha}
J. Biol. Chem., July 1, 2005; 280(26): 24356 - 24362.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
H. F. Escobar-Morreale, M. Luque-Ramirez, and J. L. San Millan
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Endocr. Rev., April 1, 2005; 26(2): 251 - 282.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
D. Ait-Ali, V. Turquier, L. Grumolato, L. Yon, M. Jourdain, D. Alexandre, L. E. Eiden, H. Vaudry, and Y. Anouar
The Proinflammatory Cytokines Tumor Necrosis Factor-{alpha} and Interleukin-1 Stimulate Neuropeptide Gene Transcription and Secretion in Adrenochromaffin Cells via Activation of Extracellularly Regulated Kinase 1/2 and p38 Protein Kinases, and Activator Protein-1 Transcription Factors
Mol. Endocrinol., July 1, 2004; 18(7): 1721 - 1739.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. T. Todorov, S. Volkl, M. Muller, A. Bohla, J. Klar, L. A. Kunz-Schughart, T. Hehlgans, and A. Kurtz
Tumor Necrosis Factor-{alpha} Activates NF{kappa}B to Inhibit Renin Transcription by Targeting cAMP-responsive Element
J. Biol. Chem., January 9, 2004; 279(2): 1458 - 1467.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. M. Fernandez-Real and W. Ricart
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Endocr. Rev., June 1, 2003; 24(3): 278 - 301.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Dzienis-Straczkowska, M. Straczkowski, M. Szelachowska, A. Stepien, I. Kowalska, and I. Kinalska
Soluble Tumor Necrosis Factor-{alpha} Receptors in Young Obese Subjects With Normal and Impaired Glucose Tolerance
Diabetes Care, March 1, 2003; 26(3): 875 - 880.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Straczkowski, I. Kowalska, A. Stepien, S. Dzienis-Straczkowska, M. Szelachowska, and I. Kinalska
Increased Plasma-Soluble Tumor Necrosis Factor-{alpha} Receptor 2 Level in Lean Nondiabetic Offspring of Type 2 Diabetic Subjects
Diabetes Care, October 1, 2002; 25(10): 1824 - 1828.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
O. M.E. Albagha, P. N. Tasker, F. E.A. McGuigan, D. M. Reid, and S. H Ralston
Linkage disequilibrium between polymorphisms in the human TNFRSF1B gene and their association with bone mass in perimenopausal women
Hum. Mol. Genet., September 15, 2002; 11(19): 2289 - 2295.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B. Peral, J. L. San Millan, R. Castello, P. Moghetti, and H. F. Escobar-Morreale
The Methionine 196 Arginine Polymorphism in Exon 6 of the TNF Receptor 2 Gene (TNFRSF1B) Is Associated with the Polycystic Ovary Syndrome and Hyperandrogenism
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3977 - 3983.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
H. Al-Kateb, S. Bahring, K. Hoffmann, K. Strauch, A. Busjahn, G. Nurnberg, M. Jouma, E. K.F. Bautz, H. A. Dresel, and F. C. Luft
Mutation in the ARH Gene and a Chromosome 13q Locus Influence Cholesterol Levels in a New Form of Digenic-Recessive Familial Hypercholesterolemia
Circ. Res., May 17, 2002; 90(9): 951 - 958.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. L. Welch, S. Bretschger, N. Latib, M. Bezouevski, Y. Guo, N. Pleskac, C.-P. Liang, C. Barlow, H. Dansky, J. L. Breslow, et al.
Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model
PNAS, July 3, 2001; 98(14): 7946 - 7951.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. V. Benjafield, C. L. Glenn, X. L. Wang, S. Colagiuri, and B. J. Morris
TNFRSF1B in Genetic Predisposition to Clinical Neuropathy and Effect on HDL Cholesterol and Glycosylated Hemoglobin in Type 2 Diabetes
Diabetes Care, April 1, 2001; 24(4): 753 - 757.
[Abstract] [Full Text]

Home page
 Physiol. GenomicsHome page
M. R. Garrett and J. P. Rapp
Two closely linked interactive blood pressure QTL on rat chromosome 5 defined using congenic Dahl rats
Physiol Genomics, February 28, 2002; 8(2): 81 - 86.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.